Format

Send to

Choose Destination
Clin Med (Lond). 2009 Feb;9(1):68-73.

Testing challenges: evaluation of novel diagnostics and molecular biomarkers.

Author information

1
PHG Foundation, Cambridge. ron.zimmern@phgfoundation.org

Abstract

Through the lens of public health genomics, this article probes certain issues that concern the evaluation of diagnostic tests and molecular biomarkers, and the accompanying policy and regulatory implications. It begins with some conceptual remarks followed by a discussion of evaluation, translation, and regulation, and their importance for public health.

PMID:
19271607
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center